Myomo Inc

Healthcare US MYO

5.04USD
-0.32(5.97%)

Last update at 2025-03-26T16:48:00Z

Day Range

5.025.39

LowHigh

52 Week Range

0.375.58

LowHigh

Fundamentals

Previous Close 5.36
Market Cap116.41M
Volume275782
P/E Ratio-
Dividend Yield-%
EBITDA-7.84225M
Revenue TTM18.53M
Revenue Per Share TTM0.82
Gross Profit TTM 10.25M
Diluted EPS TTM-0.49

Overview
Financials
Peer Comparison
Reports
Stock Research & News
Profile

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Income before tax	-10.65109M	-10.28340M	-11.56391M	-10.71301M	-10.31674M
Minority interest	-	-	-	-	-
Net income	-10.72102M	-10.37233M	-12.03862M	-10.63101M	-10.31674M
Selling general administrative	18.44M	18.02M	13.82M	11.55M	10.41M
Selling and marketing expenses	-	-	-	-	-
Gross profit	10.25M	10.31M	4.98M	2.92M	1.72M
Reconciled depreciation	0.54M	0.34M	0.11M	0.10M	0.07M
Ebit	-10.67220M	-10.26806M	-10.50269M	-10.79500M	-10.56469M
Ebitda	-10.12958M	-9.93210M	-10.39402M	-10.89436M	-10.49500M
Depreciation and amortization	0.54M	0.34M	0.11M	-0.09936M	0.07M
Non operating income net other	-	-	-1.06123M	0.08M	0.21M
Operating income	-10.67220M	-10.26806M	-10.50269M	-10.79500M	-10.52842M
Other operating expenses	26.23M	24.12M	18.09M	14.63M	12.97M
Interest expense	0.09M	0.02M	0.47M	0.00000M	0.36M
Tax provision	0.07M	0.09M	0.00000M	0.00000M	0.00000M
Interest income	0.02M	0.02M	0.35M	0.08M	0.21M
Net interest income	0.09M	-0.01534M	-0.47471M	-0.11249M	0.18M
Extraordinary items	-	-	-	-	-
Non recurring	-	-	-	-	-
Other items	-	-	-	-	-
Income tax expense	0.07M	0.09M	0.47M	-0.08199M	-0.24795M
Total revenue	15.56M	13.86M	7.58M	3.84M	2.44M
Total operating expenses	20.93M	20.58M	15.49M	13.72M	12.24M
Cost of revenue	5.30M	3.54M	2.60M	0.92M	0.73M
Total other income expense net	0.02M	-0.01534M	-1.06123M	0.08M	0.04M
Discontinued operations	-	-	-	-	-
Net income from continuing ops	-10.72102M	-10.37233M	-11.56391M	-10.71301M	-10.31674M
Net income applicable to common shares	-10.72102M	-11.01228M	-12.23454M	-11.51065M	-10.31674M
Preferred stock and other adjustments	-	-	-	-	-

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Total assets	10.16M	20.10M	14.71M	6.60M	8.28M
Intangible assets	-	-	-	-	-
Earning assets	-	-	-	-	-
Other current assets	0.57M	0.89M	0.57M	0.82M	0.70M
Total liab	3.80M	4.69M	3.14M	4.77M	1.86M
Total stockholder equity	6.36M	15.41M	11.57M	1.82M	6.43M
Deferred long term liab	-	-	0.00150M	0.22M	0.14M
Other current liab	0.05M	3.03M	2.67M	1.67M	0.00366M
Common stock	0.00077M	0.00069M	0.00046M	0.00006M	0.00125M
Capital stock	0.00077M	0.00069M	0.00046M	0.00006M	0.00125M
Retained earnings	-88.78324M	-78.06222M	-67.68989M	-56.12598M	-45.28953M
Other liab	0.00050M	0.00125M	0.12M	0.00150M	-
Good will	-	-	-	-	-
Other assets	0.11M	19.82M	0.26M	0.29M	0.22M
Cash	5.35M	15.52M	12.24M	4.47M	6.54M
Cash and equivalents	5.35M	15.52M	12.24M	4.47M	6.54M
Total current liabilities	3.60M	4.28M	2.87M	3.88M	1.86M
Current deferred revenue	0.02M	0.19M	0.00251M	0.00295M	0.11M
Net debt	-4.79206M	-14.78938M	-12.06782M	-1.81261M	-6.54079M
Short term debt	0.35M	0.33M	0.02M	1.76M	1.32M
Short long term debt	-	-	-	1.76M	-
Short long term debt total	0.55M	0.74M	0.17M	2.65M	-
Other stockholder equity	95.10M	93.53M	79.27M	57.95M	51.81M
Property plant equipment	0.70M	0.91M	0.10M	0.15M	0.19M
Total current assets	9.22M	19.19M	14.45M	6.15M	7.87M
Long term investments	0.13M	-	-	-	-
Net tangible assets	6.36M	15.41M	11.57M	1.82M	6.43M
Short term investments	-	-	-	-	-
Net receivables	1.90M	1.96M	0.92M	0.42M	0.38M
Long term debt	-	-	0.00000M	0.89M	-
Inventory	1.40M	0.81M	0.71M	0.44M	0.26M
Accounts payable	3.18M	0.72M	0.18M	0.45M	0.43M
Total permanent equity	-	-	-	-	-
Noncontrolling interest in consolidated entity	-	-	-	-	-
Temporary equity redeemable noncontrolling interests	-	-	-	-	-
Accumulated other comprehensive income	0.04M	-0.06068M	-0.01269M	-0.19228M	-0.10012M
Additional paid in capital	-	-	-	-	-
Common stock total equity	-	-	0.00046M	0.00006M	0.00125M
Preferred stock total equity	-	-	-	-	-
Retained earnings total equity	-	-	-67.68989M	-56.12598M	-45.28953M
Treasury stock	-	-0.00646M	-0.00646M	-0.00646M	-0.00646M
Accumulated amortization	-	-	-	-	-
Non currrent assets other	0.11M	-	0.17M	0.29M	0.22M
Deferred long term asset charges	-	-	-	-	-
Non current assets total	0.95M	0.91M	0.26M	0.45M	0.41M
Capital lease obligations	0.55M	0.74M	0.17M	-	-
Long term debt total	0.00000M	0.00000M	0.00000M	0.89M	0.00000M

Breakdown	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Type	yearly	yearly	yearly	yearly	yearly
Date	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31
Investments	-0.31079M	-0.32646M	-0.04575M	-0.05199M	-0.12687M
Change to liabilities	-0.69224M	1.11M	1.34M	0.06M	0.36M
Total cashflows from investing activities	-0.31079M	-0.32646M	-0.04575M	-0.05199M	-0.12687M
Net borrowings	0.38M	0.38M	-1.95908M	2.79M	2.79M
Total cash from financing activities	0.38M	13.17M	16.78M	8.32M	3.34M
Change to operating activities	-0.19779M	-0.53423M	0.43M	-0.35758M	-0.30711M
Net income	-10.72102M	-10.37233M	-11.56391M	-10.71301M	-10.31674M
Change in cash	-10.17841M	3.28M	7.70M	-2.07534M	-6.39558M
Begin period cash flow	15.52M	12.24M	4.54M	6.62M	13.01M
End period cash flow	5.35M	15.52M	12.24M	4.54M	6.62M
Total cash from operating activities	-10.23354M	-9.54769M	-9.03290M	-10.34182M	-9.60631M
Issuance of capital stock	0.38M	1.10M	18.55M	5.60M	0.00000M
Depreciation	0.54M	0.34M	0.11M	0.10M	0.07M
Other cashflows from investing activities	-0.19900M	-0.32646M	-0.32646M	-0.05199M	-0.12687M
Dividends paid	-	-	-	-	-
Change to inventory	-0.60740M	-0.11822M	-0.27154M	-0.21356M	-0.14082M
Change to account receivables	0.05M	-1.04628M	-0.52294M	-0.04203M	-0.10149M
Sale purchase of stock	0.38M	13.17M	13.67M	5.60M	3.41M
Other cashflows from financing activities	-0.31079M	12.07M	0.19M	2.71M	3.34M
Change to netincome	1.39M	1.08M	1.53M	0.96M	0.86M
Capital expenditures	0.11M	0.33M	0.05M	0.05M	0.13M
Change receivables	-	-	-0.52294M	-0.04203M	-0.10149M
Cash flows other operating	-	-	0.19M	-0.55206M	-0.34338M
Exchange rate changes	-	-	-	-	-
Cash and cash equivalents changes	-	-	7.70M	-2.07534M	-6.39558M
Change in working capital	-1.44998M	-0.58801M	0.85M	-0.55001M	-0.18657M
Stock based compensation	1.19M	1.10M	0.61M	0.91M	0.81M
Other non cash items	0.20M	-0.01993M	0.36M	0.18M	-0.03627M
Free cash flow	-10.34534M	-9.87416M	-9.07865M	-10.39381M	-9.73318M

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company	Change (USD)	Price (USD)	Trailing PE (x)	Forward PE (x)	Price Sales TTM (x)	Price to Book Value (x)	Enterprise Value to Revenue (x)	Enterprise Value to EBITDA (x)
MYO Myomo Inc	-0.32 5.97%	5.04	-	-	6.24	9.81	5.28	-13.133
ABT Abbott Laboratories	0.86 0.69%	126.47	37.15	23.15	4.67	4.97	4.88	19.38
SYK Stryker Corporation	-5.715 1.53%	367.15	44.07	24.94	5.51	6.12	6.05	25.73
MDT Medtronic PLC	- -%	88.59	26.60	15.87	3.35	2.08	3.90	14.12
BSX Boston Scientific Corp	-1.185 1.15%	101.89	68.17	24.57	5.85	4.26	6.46	26.80

Reports Covered

View All

Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, Germany, China, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, rehabilitation hospitals and surgery centers, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Myomo Inc

137 Portland Street, Boston, MA, United States, 02114

617 996 9058
https://www.myomo.com
Employees : 100

Key Executives

Name	Title	Year Born
Mr. Paul R. Gudonis	Chairman, Pres & CEO	1955
Mr. David A. Henry	Chief Financial Officer	1961
Mr. Micah J. Mitchell	Chief Commercial Officer	1976
Dr. Harry Kovelman M.D.	Chief Medical Officer	1959

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.